Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. Jul-Sep 2010;16(3):194-7.
doi: 10.4103/1319-3767.65197.

Grape Seed Extract to Improve Liver Function in Patients With Nonalcoholic Fatty Liver Change

Free PMC article
Comparative Study

Grape Seed Extract to Improve Liver Function in Patients With Nonalcoholic Fatty Liver Change

Manouchehr Khoshbaten et al. Saudi J Gastroenterol. .
Free PMC article


Background/aim: Therapeutic interventions in nonalcoholic fatty liver disease are limited, while anti-oxidative materials have shown benefits in animal models. This study aimed to evaluate grape seed extract as an anti-oxidative material in this process. Therapeutic effects of grape seed extract were evaluated in comparison to vitamin C in a double-blind setting.

Materials and methods: Fifteen patients were enrolled in each group. Liver function tests were done; also, grade of steatosis and pattern of echogenicity of the liver were determined. Patients were followed up by the same evaluation repeated in first, second and third months.

Results: Mean age +/- standard deviation was 43.2 +/- 10.3 years. Grape seed extract (GSE) significantly improved the grade of fatty liver change; and resulted in significant decrease in alanine aminotransferase in patients receiving the concentrate compared to those receiving vitamin C independently, from the initial grade of steatosis.

Conclusions: This study describes the beneficial effect of using grape seed extract for three months in patients with nonalcoholic fatty liver disease. These results may improve with a longer period of follow-up.

Conflict of interest statement

Conflict of Interest: None declared.


Figure 1
Figure 1
Estimated marginal means of serum liver test results in patients receiving grape seed extract for three months (AST: aspartate transaminase, ALT: alanine transaminase, ALP: alkaline phosphatase. *: The decrease reaches statistical significance)

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles


    1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31. - PubMed
    1. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999;30:1356–62. - PubMed
    1. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2003;98:2485–90. - PubMed
    1. Patrick L. Nonalcohoic fatty liver disease: Relationship to insulin sensitivity and oxidative stress: Treatment approaches using vitamin E, magnesium and betaine. Altern Med Rev. 2002;7:276–91. - PubMed
    1. Sehirli O, Ozel Y, Dulundu E, Topaloglu U, Ercan F, Sener G. Grape seed extract treatment reduces hepatic ischemia-reperfusion injury in rats. Phytother Res. 2008;22:43–8. - PubMed

Publication types